Trident Lifeline (BOM:543616) has partnered with National Institutes of Pharmaceutical Education and Research, Ahmedabad, India, for the technology transfer of Vorinostat, a drug used in cancer treatment, according to an Indian bourse filing on Wednesday.
The company plans to scale up production and introduce it to the Indian market, aiming to improve access and affordability for patients, the filing said.
Trident Lifeline shares were up 5.8% in recent trading.
Price (INR): ₹283.75, Change: ₹+16, Percent Change: +5.82%